combination glp 1 and sglt2 Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology GLP-1 Receptor Agonists and SGLT2

Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular [PMID: 38215986] Laboratory literature summary: Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide

New treatments like MariTide, combining GLP-1 activation with GIP inhibition, might offer a new approach to managing type 2 diabetes and obesity-related conditions

The peptide appears to reduce toxicity from various drugs in animal models, which might alter the effectiveness of other medications

Free radicals are byproducts of normal cell activity which participate in chemical reactions within cells